University of California San Francisco

Give to UCSF

In the Face of Cuts, W.M. Keck Foundation Supports Vital Research

Six pairs of UC San Francisco faculty members and their PhD students have been awarded funding through the W. M. Keck Foundation’s inaugural Scholar-Fellow Bridge Initiative, a program designed to sustain promising early-career scientists and their trainees during the current period of uncertainty in federal research funding.

UC Regents Approve New UCSF Bakar Ear & Hearing Institute

The University of California Board of Regents approved plans for the UCSF Bakar Ear & Hearing Institute, a new, state-of-the-art ear facility at UCSF’s Mission Bay campus, taking the first step to creating one of the world’s leading centers for advancing research and care for hearing and balance disorders.

UCSF Community Honors Life of Doris Fisher (1931 – 2026)

Doris Fisher, a visionary philanthropist and longtime champion of UCSF who passed away in May 2026, devoted more than four decades to advancing the university’s mission. She served as a Lifetime Director on the UCSF Foundation Board and played a key role in building the UCSF Foundation.

Are Your Meds and DNA a Bad Match? This Test Alerts Clinicians

Differences in people’s genes can affect how they respond to medications, including how well a drug works and the chances of side effects. About 1 in 10 of prescriptions given to patients outside the hospital don’t work as well as they should because of differences in people’s genes, according to a review of U.S. studies by UC San Francisco health economics professor Kathryn Phillips, PhD, and colleagues.

Can Blockbuster GLP-1 Weight-Loss Drugs Also Protect Brain Health?

Multiple clinical trials have shown that GLP-1s are safe and effective for patients with obesity, diabetes and cardiovascular conditions. New evidence shows that the drugs may also protect against neurological diseases, like dementia, Parkinson's, and substance use disorder.
Subscribe to